April 28th 2025
Your daily dose of the clinical news you may have missed.
April 25th 2025
At current vaccination rates, measles could become endemic in the US again within 21 years; the threat extends to rubella, polio, and diphtheria, the study found.
April 17th 2025
The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.
April 15th 2025
Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.
April 9th 2025
AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 23, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 20, 2022
CDC Greenlights COVID-19 Booster for Children Aged 5 to 11 Years
The CDC is encouraging parents of children in this age group to first finish a primary vaccination series, saying only 28% now are in that category.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022
FDA Authorizes Pfizer-BioNTech COVID-19 Booster for Children Aged 5 to 11 Years
Children aged 5 to 11 years can receive a single dose booster shot 5 months after completing a primary 2-dose series of the Pfizer COVID-19 vaccine, FDA says.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 12, 2022
Shingrix: Who Needs It and Who Doesn't?
A 55-year-old healthy man has a rash on his back that is diagnosed as shingles. He has never received any shingles vaccine–is he eligible now? Plus 3 more patient scenarios.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 9, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 4, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 2, 2022
Study: Investigational RSV Vaccine Elicited Neutralizing Antibody Responses in Pregnant Women
Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.
Remdesivir Wins FDA Approval for Treatment of COVID-19 in Youngest Patients
The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.
Moderna Announces Filing for Emergency Use Authorization for its COVID-19 Vaccine in Children Under Age 6 Years
The biotechnology company said on Thursday that similar requests are underway with international regulatory authorities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 27, 2022
COVID-19 Epilogue: 10 Lessons Learned During 2 Long Years
Infectious disease expert and clinical investigator Rodger MacArthur, MD, considers what we know now that we didn't on March 12, 2020.
7 Questions on Latest US STD Trends
SAMPLE: Between 2019 and 2020, the rate of reported gonorrhea increased 10%. True or false? Plus, 6 more questions based on the CDC’s 2020 STD Surveillance Report.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 21, 2022
Preliminary Results Support Feasibility, Immunogenicity of Influenza-COVID-19 Combo Vaccine
Novavax reports that the various combinations assessed were safe and induced immune responses comparable to stand-alone formulations of both vaccines.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 20, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 19, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 18, 2022
FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
The FDA recently announced it had issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with SARS-CoV-2 infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 13, 2022